Duration of Red Blood Cell Storage Prior to Transfusion

NCT ID: NCT02087514

Last Updated: 2018-04-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will determine the minimal duration of red blood cell (RBC) storage that leads to increases in circulating non-transferrin-bound iron in healthy human volunteers post-transfusion. The results from this study will help guide national guidelines for appropriate duration of RBC storage prior to transfusion, which is currently 6 weeks by Food and Drug Administration (FDA) criteria. The overall objective of this research is to improve the safety of refrigerated storage of red blood cells before transfusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Recent studies suggest that older stored blood is associated with worse outcomes in certain hospitalized patients. Red cells may be stored in a refrigerator prior to transfusion for up to 42 days by current FDA standards. Refrigerator storage of red cells is associated with a storage lesion and the survival of transfused red cells decreases with increasing storage time, thus older blood is associated with an increased delivery of hemoglobin-iron to certain parts of the body. The investigators have preliminary data in mice and humans suggesting that delivery of a significant iron load from aged red cells leads to the production of a potentially toxic form of circulating iron called non-transferrin-bound iron.

In this prospective study of healthy volunteers, each subject will be randomized to receive transfusion of one RBC unit after 1, 2, 3, 4, 5, or 6 weeks of storage. The primary outcome will be the 24 hr area under the curve (AUC) of the serum non-transferrin bound iron concentration calculated from samples collected at 0, 2, 4, 6, 8, 10, 12, 14 and 24 hours after transfusion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron, Blood Level Abnormal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transfusion of PRBC stored for 1 week

Subjects will receive blood transfusion with packed red blood cells stored for 1 week.

Group Type ACTIVE_COMPARATOR

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Transfusion of PRBC stored for 2 weeks

Subjects will receive blood transfusion with packed red blood cells stored for 2 weeks.

Group Type EXPERIMENTAL

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Transfusion of PRBC stored for 3 weeks

Subjects will receive blood transfusion with packed red blood cells stored for 3 weeks.

Group Type EXPERIMENTAL

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Transfusion of PRBC stored for 4 weeks

Subjects will receive blood transfusion with packed red blood cells stored for 4 weeks.

Group Type EXPERIMENTAL

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Transfusion of PRBC stored for 5 weeks

Subjects will receive blood transfusion with packed red blood cells stored for 5 weeks.

Group Type EXPERIMENTAL

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Transfusion of PRBC stored for 6 weeks

Subjects will receive blood transfusion with packed red blood cells stored for 6 weeks.

Group Type EXPERIMENTAL

Blood Transfusion

Intervention Type PROCEDURE

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Packed red blood cells

Intervention Type OTHER

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood Transfusion

A routine medical procedure in which blood is given through an intravenous (IV) line a blood vessel.

Intervention Type PROCEDURE

Packed red blood cells

Red blood cells that have been collected, processed, and stored in bags as blood product units available for blood transfusion.

A standard autologous leukoreduced packed red blood cell unit will be collected and stored in AS-3 solution in the Columbia University Medical Center blood bank.

The number of weeks in storage are as follows:

* 1 week
* 2 weeks
* 3 weeks
* 4 weeks
* 5 weeks
* 6 weeks

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Red blood cell (RBC) transfusion PRBC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years old
* Body weight \>110 lbs
* Hemoglobin \>12.5 g/dL

Exclusion Criteria

* Ineligible for donation based on the New York Blood Center blood donor questionnaire
* Systolic blood pressure \>180 or \<90 mm Hg, diastolic blood pressure \>100 or \<50 mm Hg
* Heart rate \<50 or \>100
* Temperature \>99.5 F prior to donation
* Temperature \>100.4 F or subjective feeling of illness prior to transfusion (this is to avoid having a concurrent illness affect post-transfusion measurements);
* Positive results on standard blood donor infectious disease testing
* Positive urine pregnancy test
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Columbia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Steven L. Spitalnik

Professor of Pathology and Cell Biology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Steven L Spitalnik, MD

Role: PRINCIPAL_INVESTIGATOR

Columbia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Columbia University Medical Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H, Schwartz J, Eisenberger A, Soffing M, Yeh R, Divgi C, Ginzburg YZ, Shaz BH, Sheth S, Francis RO, Spitalnik SL, Hod EA. Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest. 2017 Jan 3;127(1):375-382. doi: 10.1172/JCI90837. Epub 2016 Dec 12.

Reference Type DERIVED
PMID: 27941245 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HL115557

Identifier Type: NIH

Identifier Source: secondary_id

View Link

AAAI0835

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hemoglobin and Iron Recovery Study
NCT01555060 COMPLETED PHASE2
RH Genotype Matched RBC Transfusions
NCT04156893 RECRUITING PHASE1/PHASE2